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Abstract 
Background: Training on a professional level can lead to cardiac structural adaptations called 
the “athlete’s heart”. As marathon participation requires intense physical preparation, the 
question arises whether the features of “athlete’s heart” can also develop in recreational 
runners. 
Methods: The study included 34 males (mean age 40 ± 8 years) who underwent physical 
examination, a cardiopulmonary exercise test and echocardiographic examination (ECHO) 
before a marathon. ECHO results were compared with the sedentary control group, reference 
values for an adult male population and those for highly-trained athletes. Runners with 
abnormalities revealed by ECHO were referred for cardiac magnetic resonance imaging 
(CMR). 
Results: The mean training distance was 56.5 ± 19.7 km/week, peak oxygen uptake was 53.7 
± 6.9 mL/kg/min and the marathon finishing time was 3.7 ± 0.4 h. Compared to sedentary 
controls, amateur athletes presented larger atria, increased left ventricular (LV) wall 
thickness, larger LV mass and basal right ventricular (RV) inflow diameter (p < 0.05). When 
compared with ranges for the general adult population, 56% of participants showed increased 
left atrial volume, indexed to body surface area (LAVI), 56% right atrial area and 
interventricular septum thickness, while 47% had enlarged RV proximal outflow tract 
diameter. In 50% of cases, LAVI exceeded values reported for highly-trained athletes. Due to 
ECHO abnormalities, CMR was performed in 6 participants, which revealed hypertrophic 
cardiomyopathy in 1 runner.  
Conclusions: “Athlete’s heart” features occur in amateur marathon runners. In this group, 
ECHO reference values for highly-trained elite athletes should be considered, rather than 
those for the general population and even then LAVI can exceed the upper normal value. 
Key words: echocardiography, cardiac magnetic resonance, athlete’s heart, marathon 
runners; sport cardiology, hypertrophic cardiomyopathy 
 
 
Introduction 
Regular and moderate physical activity has a positive effect in humans, however the 
“upper dose” of beneficial endurance exercise has not been determined [1, 2]. Participation in 
sport events like marathon runs has recently become very popular. The characteristics of 
marathon runners is evolving, with a growing percentage of non-elite amateur runners who 
are often middle-aged [3]. Long-term endurance training on a professional level can lead to 
multiple structural adaptations, called the “athlete’s heart” [4]. As marathon participation 
requires intense physical preparation, the question arises whether the features of “athlete’s 
heart” can be present in recreational runners. And if so, which echocardiographic criteria 
should be applied in this group: those for the general adult population or those for highly 
trained elite athletes.  
 
Methods  
Study participants and study protocol 
Male amateur marathon runners who planned to attend the 2nd PZU Marathon in 
Gdansk, Poland were recruited by invitation to local running clubs. Volunteers were informed 
about the purpose and plan of the study and gave written consent. All participants were 
questioned about medical history and those with chronic diseases, or at age < 20, or > 55 
years were not eligible. Two weeks before the marathon run, each of the participants 
underwent physical examination, treadmill cardiopulmonary exercise test (CPET) and 
echocardiographic examination (ECHO).  
Fifteen sedentary males matched with age, body mass index (BMI) and body surface 
area (BSA) with marathon runners constituted the control group for ECHO. They were 
healthy men without any history of practicing endurance exercise. In the next step, data 
obtained in marathon runners were compared with reference values for cardiac chambers in 
male adults, provided by the American Society of Echocardiography and European 
Association of Cardiovascular Imaging [5]. Subsequently, results were also compared with 
reference values for elite athletes: 1) right chamber’s dimensions with Normative Reference 
Values of Right Heart in Competitive Athletes [6], and 2) left chambers diameters with values 
reported in studies on populations of elite athletes [4, 6–8], as to our knowledge there is no 
single paper providing all normative reference values for the left heart in this group.  
The study protocol set up that participants with abnormalities revealed by ECHO were 
referred for cardiac magnetic resonance imaging (CMR). These included: increased 
interventricular septum diameter (≥ 13 mm), abnormal left ventricular (LV) contractility 
(ejection fraction < 52% or abnormal global longitudinal strain > –18.9%), abnormal right 
ventricular (RV) systolic function (tricuspid annular plane systolic excursion < 17 mm, RV 
strain of > –20% or spectral tissue Doppler derived tricuspid lateral annulus peak systolic 
velocity < 9.5 cm/s) [5, 9, 10]. The study protocol was accepted by Independent Bioethics 
Commission for Research of the Medical University of Gdansk (NKBBN/104/2016).  
 Cardiopulmonary exercise test  
Cardiopulmonary exercise test was performed on the treadmill (H/P/Cosmos Saturn 
treadmill) using the Bruce protocol. First stage started at 2.7 km/h and at 10% gradient, then 
the speed and incline were increased in 3 min intervals. Jaeger OxyconPro equipment with 
Jlab Manager V5.32.0 software was used to measure the oxygen intake (VO2), carbon dioxide 
output (VCO2), minute ventilation (VE), expiratory gas concentrations throughout the 
respiratory cycle on a breath-by-breath basis. The peak oxygen intake (VO2peak) was 
calculated as the highest volume averaged over 10 s at maximal endurance. The anaerobic 
threshold (AT) was calculated with the V-slope method and was corrected by the ventilator 
equivalent method.  
 
Echocardiography  
Transthoracic ECHO was performed using Vivid E9 (General Electric Medical 
Health) in marathon runners and sedentary controls. ECHO measurements were carried out 
according to the recommendations of the American Society of Echocardiography and 
European Association of Cardiovascular Imaging [5]. Left ventricular measurements: LV end-
diastolic dimension (LV ED), LV end-systolic dimension (LV ES), diastolic interventricular 
septum (IVS) and posterior wall (LV PW) thickness, left atrial (LA) anteroposterior (AP) 
dimension and proximal RV outflow diameter (RVOT prox) were performed in the 
parasternal long-axis view. The LV end-diastolic (LV EDV) and LV end-systolic (LV ESV) 
volumes were measured with the biplane method of discs summation (the modified Simpson’s 
rule) and then LV ejection fraction (LV EF) was calculated. The 2-dimensional (2D) speckle-
tracking LV global longitudinal peak strain (LV GLS) measurements were obtained from 2-, 
3-, and 4-chamber apical views and were averaged. The LV mass was assessed by the area-
length method and was then indexed to BSA. In the end systole, the LA volume was indexed 
to BSA (LAVI) and was calculated by the area-length technique from apical 2- and 4-
chamber views, whereas the right atrial (RA) area was measured in the apical 4-chamber 
view. The basal RV inflow diameter (RVd) and the 2D speckle-tracking-derived RV strain 
were obtained in the RV-focused apical 4-chamber view. The RV systolic function was 
assessed by measuring the tricuspid annular plane systolic excursion (TAPSE) in the M-mode 
and spectral tissue Doppler-derived tricuspid lateral annulus systolic peak velocity (S’RV). 
The offline analyses of data were carried out using commercially available software — 
EchoPack 201 (General Electric). 
Cardiac magnetic resonance  
Cardiac magnetic resonance examinations were performed with a 1.5 Tesla scanner 
(Magnetom Aera, Siemens Healthcare) with an 18-channel phased-array receiver coil with 
repeated breath-holds, according to protocol [11]. Segmented steady-state free-precession 
sequence was used to acquire cine images of the heart in 2-, 3-, and 4-chamber views, as well 
as in short-axis views to obtain a stack of contiguous short-axis slices which include the entire 
LV and RV having a slice thickness of 8 mm with 2 mm gaps. In the majority of cases the 
parallel acquisition technique with acceleration factor of 2 was used. Late gadolinium 
enhancement (LGE) was assessed 7–15 min post administration of gadolinium-based contrast 
agent at a dose of 0.1 mmol/kg body mass, with an inversion recovery spoiled gradient echo 
sequence (single slice per breath hold). Inversion time was repeatedly optimized to null 
normal myocardium. A short-axis stack identical to that performed in cine steady-state free 
precession as well as 2-, 3-, and 4-chamber long axis images (slice thickness of 8 mm with in-
plane resolution typically ca 1.5 × 1.5 mm) were acquired in each individual. Data was 
analyzed using commercially available software by an experienced observer.  
 
Statistical analysis 
Continuous variables are presented as mean ± standard deviations (SD) or median and 
range. The Shapiro-Wilk test was used to estimate the distribution. A comparison of the 
amateur marathon runners and controls was performed by the Student t-test for independent 
samples or the Mann–Whitney U test where appropriate. A p value < 0.05 was considered 
statistically significant. The data were analyzed using Statistica 13 software (Statsoft Poland).  
 
Results 
Thirty-four amateur marathon runners were included in the study. Results of 
electrocardiographic examination in these subjects have recently been published [12]. Table 1 
shows data on training habits and CPET. Table 2 presents features of marathon runners in 
comparison with sedentary controls. There were no significant differences in age, weight, 
height, BSA and BMI between amateur runners and controls (p > 0.05). All participants were 
healthy men of Caucasian race. 
Data on ECHO parameters obtained in the amateur marathon runners studied and 
sedentary controls are presented in Table 2. Compared to controls, amateur athletes had larger 
atria, increased LV wall thickness, larger LV mass and RVd (p < 0.05). There were no 
differences regarding other ECHO parameters. A comparison of parameters obtained from 
amateur marathon runners with reference values for the general male adult population and for 
professional athletes is presented in Table 3. It shows the percentage of amateur athletes 
exceeding the upper reference value for the adult population (URP) and the upper value range 
for highly-trained athletes (URA). The IVS population norm of 10 mm was exceeded in 19 
(56%) runners and in 3 (9%) participants it was ≥ 13 mm (13 mm, 14.7 mm and 17 mm). The 
LV PW was ≥ 13 mm in 2 runners (13.6 mm and 14 mm). One subject was diagnosed with 
hypertrophic cardiomyopathy (HCM). All participants with LV enlargement (as indicated by 
LV EDV) showed IVS > 10 mm, but only 3 runners with IVS > 10 mm presented with an 
enlarged LV. One runner had mildly abnormal LV EF of 51%. The LV GLS was abnormal in 
4 (12%) runners (> –18.9%) whereas the RV strain was altered in 6 (18%) amateurs (> –
20%). The median S’RV was 14 cm/s (range 9–19 cm/s). In 1 participant the abnormal S’RV 
below 9.5 cm/s was found, whereas TAPSE was within normal ranges. 
There was a negative correlation between the achieved marathon times and training 
distance (r = –0.4, p < 0.05) or oxygen uptake at the anaerobic threshold (VO2AT) (r = –0.38, 
p < 0.05). The training distance [km/week] correlated with LAVI (r = 0.44, p < 0.05). The RA 
area correlated with LAVI (r = 0.46, p < 0.05) and RVd (r = 0.49, p < 0.05). 
The CMR was performed in 6 (18%) amateur marathon runners. The reasons for the 
CMR referral are presented in Table 4; all showed several abnormalities in ECHO and the 
most frequent was increased IVS. Results from CMR imaging are presented in Tables 4 and 5. 
The major abnormality was enlarged volume and depressed RV function. The RV ESV was 
increased in all runners and RV EDV in 1 individual. All those 6 participants presented 
reduced RV EF with a median of 46%. The LV was enlarged in 3 subjects (LV ESV was 
increased in all of them, while LV EDV in 1). In 3 participants LV EF was slightly below the 
lower reference limit. In 1 participant CMR imaging confirmed HCM with asymmetric 
hypertrophy (LVH) of LV segments: basal infero-septum and basal antero-septum with 
maximum wall thickness of 17 mm. In addition, the LGE revealed myocardial fibrosis within 
hypertrophic ventricular segments. LGE was present only in this participant. In addition, in 1 
individual CMR raised suspicion of atrial septum defect of 6 mm in diameter.  
Discussion  
The study group represented a non-elite runner population. However, the reported 
finishing times vary between studies, the average time of the marathon run among amateur 
participants oscillates around 3.5 h, similar to the present group [13]. Professional athletes 
cover this distance within 2.3 h [14]. Regarding training volumes, the weekly distance in 
highly-trained elite and national-class runners is 145.3 ± 25.6 km [14], whereas in the current 
group it was 56.5 ± 19.7 km, comparable to other studies on amateurs [15]. The mean 
VO2peak was similar to those previously reported among runners with comparable running 
performance [13]. The more time subjects spent on training the better marathon time they 
achieved. The VO2AT appeared to be prognostic for obtained outcome at the finishing-line. 
Training-induced changes in cardiac morphology, named the “athlete’s heart” are a 
common finding among professional athletes. Recurrent exercise-induced pressure or volume 
overload causes cardiac remodeling with increased chamber dimensions, LV mass and LV 
wall thickness [4, 7]. Physiological in elite athletes, these modifications in the general adult 
population are considered pathological. Type of exercise, its intensity, duration of training, 
age, sex, race, BSA and other unrecognized individual factors can influence the occurrence of 
“athlete’s heart” [4, 16]. It can appear even after 8 weeks of intense training and may 
disappear after sport termination [17, 18]. The question arises, whether the “athlete’s heart” 
features also develop in middle-aged recreational runners. In the present group of amateur 
marathon runners, the cardiac dimensions assessed by ECHO frequently exceeded those 
obtained in sedentary controls, as well as reference ranges for the general adult population. 
Atrial enlargement was one of the most common findings and both atria were significantly 
larger in comparison to sedentary controls. Due to significant hemodynamic overload and 
increased atrial pressure during intense exercise, larger LA in professional athletes were 
expected with volumes on average of 7.0 mL/m2 greater than those met in the general 
population [19, 20]. Noteworthy, in the present study was that LAVI in amateur runners 
exceeded not only upper value ranges for the general population, but in half of them upper 
ranges were also reported for highly trained athletes. The more time runners spent on training 
the more their LA was enlarged, which was demonstrated by positive correlation between 
LAVI and weekly training distance. More than half of the current group had an enlarged RA 
area and changes in RA correlated with those of LA. Possibly, atria of amateur runners are 
especially prone to enlargement and this magnification may not happen without consequences 
— as we know that exercise-induced atrial remodeling increases the risk of atrial fibrillation 
[21]. The next important finding in the amateur runners studied was the LV thickening, which 
was significant in comparison with sedentary controls. The measurement of the wall thickness 
is especially important in differential diagnosis between physiological exercise-induced LVH 
and HCM. HCM remains one of the most common causes of sudden cardiac death in elite 
athletes and individuals with this diagnosis are advised to discontinue competitive sport 
activity [22, 23]. The LV wall of 13–14 mm is the grey zone in differential diagnosis among 
athletes and HCM patients, whereas ≥ 15 mm or evident asymmetric hypertrophy suggests 
pathology [16, 23]. The prevalence of LV wall thickness ≥ 13 mm was reported as 1.7% 
among athletes, however training-related IVS can (rarely) reach even 16 mm [7]. In the group 
studied the IVS of ≥ 13 mm was more frequent. Two cases raised suspicion of HCM, and was 
later confirmed in one individual. The recognition of HCM never relies on a single ECHO 
parameter and the assessment of diastolic function may also be helpful [16, 23]. The exercise-
related LV thickening usually corresponds with LV enlargement, whereas in HCM patients 
the LV diastolic volume is rather small [16]. In the current study, LV dilation was rarely 
encountered and IVS thickening was not observed parallel to LV enlargement. What can be 
used to differentiate “athlete’s heart” with cardiomyopathies is the speckle tracking-derived 
LV GLS assessment, which enables detection of systolic abnormalities much earlier than the 
LV EF deteriorates [23, 24]. The sedentary population norms of LV GLS vary between 
studies, according to meta-analysis it should not be > –18.9%. Nevertheless, one should take 
into account the software that was used — in EchoPAC from GE the lower limit of normal 
range for LV GLS is –18% [5, 9]. Noteworthy, LV GLS normal values for athletes resemble 
those for the general population and abnormal LV GLS (especially when > –15%) in athletes 
should not be regarded as cardiac training adaptation, but rather as pathological and should 
prompt further diagnostics [24].  
As RV remodeling is one of the most characteristic features of “athlete’s heart” it is 
necessary to apply special normative reference values for RV evaluation in elite athletes [6]. 
In healthy sportsmen, the size of RV is increased but its function is preserved, although 
according to recent meta-analysis athletes present lower RV EF in CMR than the general 
population (with mean of 52%) [25]. The RV enlargement is also typical for arrhythmogenic 
RV cardiomyopathy (ARVC), which should be ruled out in differential diagnosis [26]. In the 
present study nearly half of the amateur runners showed enlarged RV (RVOT prox). Standard 
2D echocardiographic evaluation of RV remains challenging, because of its complicated 
structure and lack of a single parameter that would precisely describe RV systolic function 
[27]. The assessment of RV is very important, as RV, may be “the Achilles heel” of the 
competing heart. In the current study 6 participants presented with slightly reduced RV 
systolic function, as indicated by abnormal RV strain and also decreased S’RV in one subject. 
It has also been shown previously in elite athletes, that adaptation for training means better 
RV deformation and that there is a correlation between training experience and RV strain; the 
more years of training — the more negative the RV strain values can be [28].  
ECHO remains the main tool in the recognition of the “athlete’s heart” and in 
differential diagnosis with cardiomyopathies. Nevertheless, CMR provides the most accurate 
estimation of both ventricles including the prevalence of myocardial fibrosis [29]. The 
presence of LGE in hypertrophic segments may suggest HCM, but it does not always mean a 
certain diagnosis [23, 30]. Generally, in elite athletes, CMR mainly demonstrates the 
biventricular enlargement of volumes: EDV and ESV [29, 31]. Usually these changes are 
symmetrical and those in the RV reflect those in the LV [25, 32]. In the present study nearly 
half of participants presented enlarged RV but it was not accompanied by an increase in LV 
diameters or volumes. These observations were previously explained as RV sensitiveness and 
an expected response to increased overload [25]. Nevertheless, current results concerning the 
RV and LV systolic function suggest difficulties of RV for amateur marathon runners to adapt 
to exercise and can support a thesis that RV as an “Achilles heel” of the competing heart. Not 
only RV but also RA may limit the heart function, as in the present group, both right heart 
chambers were dilated and the RA area and RVd correlated positively. Probably, the right 
heart of predisposed individuals, when exposed to repetitive episodes of overload, may be 
prone to irreversible damage. The recurrent extreme effort can lead to so-called Phidippides 
cardiomyopathy, in which the focal areas of cardiac fibrosis develop and become the substrate 
for ventricular arrhythmias and a reason for sudden death [33]. 
 
Conclusions  
The results of the present study demonstrate that “athlete’s heart” features do develop 
in amateur marathon runners. One of the most important findings was increased LAVI, which 
exceeded even the upper reference limit for highly-trained athletes in half of the study 
participants. It may reflect abnormal atrial response to pressure overload in recreational 
marathon runners not sufficiently adapted to endurance exercise. Another important issue was 
the high prevalence of IVS thickening among amateur athletes and a confirmed diagnosis of 
HCM in one participant. Echocardiography should play a pivotal role in the medical 
assessment of this population. In individuals with the history of marathon attendance ECHO 
reference values for highly trained elite athletes may be more helpful than those applied for 
the general adult population. CMR imaging is indicated when it is difficult to differentiate 
between physiological “athlete’s heart” remodeling and conditions like HCM.  
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Table 1. Characteristics of amateur marathon runners studied (n = 34). 
Parameter Marathon runners 
Training distance [km/week] 56.5 ± 19.7 
Training time [h/week] 6.5 ± 2.3 
Marathon finishing time [h] 3.7 ± 0.4 
Cardiopulmonary exercise test:  
 VO2peak [mL/kg/min] 53.7 ± 6.9 
VO260sec [mL/kg/min] 19.9 ± 3.7 
VO2AT [mL/kg/min] 39.7 ± 6.9  
Respiratory exchange ratio 1.2 ± 0.1 
Time of effort [min] 12:46 ± 1:24 
HR max [bpm] 178 ± 12 
HR in 180 s of recovery [bpm] 111 ± 16 
Data are shown as mean ± standard deviation; VO2peak — peak oxygen intake; VO260sec — 
oxygen intake at 60 s of recovery; VO2AT — oxygen intake at anaerobic threshold; HR — 
heart rate 
 
Table 2. Results of echocardiographic examination performed in amateur marathon runners 
and subjects from the control group. 
Parameter 
Marathon runners 
(n = 34) 
Control group (n 
= 15) 
P 
Age [years] 41 (24–55) 42 (24–55) > 0.6709^ 
Weight [kg] 80 (67–97) 80 (64–100) > 0.3878^ 
Height [cm] 180 (165–188) 177 (169–195) > 0.7643^ 
BSA [m2] 2.0 (1.8–2.2) 2.0 (1.7–2.2) > 0.5206^ 
BMI [kg/m2] 25 (19–29) 25 (22–31) > 0.2069^ 
LAVI [mL/m2] 36 (21–51) 27 (17–35) < 0.0001^ 
RA area [cm2] 19 (14–25) 16 (11–20) < 0.0005^ 
LV EDV [ml] 122 (78–176) 105 (66–164) > 0.0732^ 
LV ED [mm] 52 (45–58) 50 (39–59) > 0.0729^ 
IVS [mm] 11 (7–17) 10 (7–10) < 0.0001# 
LV PW [mm] 11 (7–14) 10 (7–11) < 0.0206^ 
LV mass [g/m2] 97 (61–117) 77 (62–108) < 0.00001^ 
LV EF [%] 66 (51–86) 62 (56–74) > 0.1896^ 
LV GLS [%] –20 [–17 – (–25)] –20 [–17 – (–23)] > 0.4363^ 
RVOT prox [mm] 30 (21–38) 30 (25–36) > 0.6764^ 
RVd [mm] 37 (25–47) 30 (27–40) < 0.0179^ 
TAPSE [mm] 24 (19–32) 23 (20–27) > 0.4550^ 
RV strain [%] –22 [–27 – (–18)] –24 [–26 – (–19)] > 0.2978^ 
Data are shown as median (range); ^The Student t-test; #The Mann–Whitney U test; BSA — 
body surface area; BMI — body mass index; LAVI — left atrial volume indexed to body 
surface area; RA — right atrial; LV — left ventricular; EDV — end-diastolic volume; ED — 
end-diastolic dimension; IVS — interventricular septum diastolic diameter; PW — posterior 
wall diameter; EF — ejection fraction; GLS — global longitudinal peak strain; RVd — right 
ventricular diameter; RVOT prox — proximal right ventricular outflow tract diameter; 
TAPSE — tricuspid annular plane systolic excursion 
 
Table 3. Results of echocardiographic examination performed in amateur marathon runners 
(n = 34) in comparison with reference ranges for the general male adult population and with 
reference ranges for professional athletes. 
Parameter 
Reference 
ranges for 
adults 
(range) 
Runners with 
values exceeding 
the upper 
reference value 
for the adult 
population 
(URP) 
N (%) 
Reference 
ranges for 
highly 
trained 
athletes 
(range) 
Runners with 
values exceeding 
the upper 
reference value 
for highly trained 
athletes (URA)  
N (%) 
LA AP [mm] 30–40[5] 13 (38) 24–48[8] 0 (0) 
LAVI [mL/m2] 16–34[5] 19 (56) 26–36[8] 17 (50) 
RA area [cm2] 10–18[10] 19 (56) 14–23[6] 3 (9) 
LV EDV [mL] 62–150[5] 3 (9) 180–340[4] 0 (0) 
LV ED [mm] 42–58[5] 0 (0) 44–66[7] 0 (0) 
IVS [mm] 6–10[5] 19 (56) 7–16[7] 1 (3) 
LV PW [mm] 6–10[5] 14 (41) 7–13[7] 2 (6) 
LV mass [g/m2] 50–102[5] 10 (29) 62–176[7] 0 (0) 
RVd [mm] 25–41[5] 5 (15) 38–42[6] 3 (9) 
RVOT prox [mm] 20–30[5] 16 (47) 26–33[6] 6 (18) 
LA AP — left atrial anteroposterior dimension. For other abbreviations see Table 2 
 
Table 4. Results of cardiac magnetic resonance imaging (CMR) performed in amateur 
marathon runners with abnormalities revealed in echocardiographic (ECHO) examination. 
No. 
Reason for CMR 
CMR results 
ECHO abnormalities 
M06 
LV GLS Avg –17%, with abnormal LV GLS pattern 
GLS 2C –16%, GLS 4C –17%, GLS Aplax –17% (n: > –
18.9%)[9] 
RVd 47 mm  
Slightly reduced LV EF (53%) and 
RV EF (44%). Enlarged LV (LV 
ESV 86 mL) and RV (RV ESV 118 
mL) 
M29 
IVS 14.7 mm  
E’LAT 8 cm/s (n: > 10 cm/s)[34] 
RV strain –19% (n: > –20%)[10] 
Slightly reduced LV EF (54%) and 
RV EF (42%), LV hypertrophy 
(IVS 13 mm), enlarged LV (LV 
ESV 79 mL) and RV (RV ESV 119 
mL) 
M38 
IVS 17 mm  
LV EF 51%  
E’SEPT 6 cm/s (n: > 7 cm/s)[34] 
LV GLS Avg –18%, abnormal LV GLS pattern 
GLS 2C –17%, GLS 4C –17% (n: > –18.9%)[9] 
RVOT prox 31 mm 
Hypertrophic cardiomyopathy (IVS 
17 mm), LGE present 
Slightly reduced RV EF (47%) and 
enlarged RV (RV ESV 97 mL) 
Increased LA area (30 cm2) 
M39 
IVS 12 mm 
LV GLS Avg –17%, abnormal LV GLS pattern 
GLS 2C –17%, GLS 4C –16% (n: > –18.9%)[9] 
RV strain –18% (n: > –20%)[10] 
LV ED 52 mm 
Slightly reduced RV EF (42%) and 
enlarged RV (RV ESV 112 mL) 
M40 
IVS 13 mm 
E’SEPT 7 cm/s (n: > 7 cm/s)[34] 
Atrial septal defect 
Slightly reduced RV EF (48%) and 
S’RV 9 cm/s (n: > 9.5 cm/s)[10] 
RV strain –19% (n: > –20%)[10] 
RVOT prox 32 mm 
LV ED 49 mm 
enlarged RV (RV ESV 103 mL) 
M41 
IVS 12 mm 
Abnormal LV GLS pattern: GLS Avg –17%, GLS 2C –16% 
(n: > –18.9%)[9] 
LV EDV 176 mL 
Slightly reduced LV EF (56%) and 
RV EF (49%). Enlarged LV (LV 
EDV 245 mL, LV ESV 107 mL) 
and RV (RV EDV 239 mL, RV 
ESV123 mL) 
For abbreviations see Table 2, for echocardiographic reference values see Table 3; values 
outside the range for adults. For cardiac magnetic resonance reference values see Table 5; No. 
— number of marathon runners; Avg — averaged; 2C — two chamber view; 4C — four 
chamber view; Aplax — apical long axis view; S’RV — spectral tissue Doppler tricuspid 
lateral annulus peak systolic velocity; LGE —late gadolinium enhancement; E’— spectral 
tissue Doppler mitral early diastolic peak velocity (SEPT — measured on IVS; LAT — 
measured on lateral wall) 
 
Table 5 Results of cardiac magnetic resonance examination (CMR) in amateur marathon 
runners. 
Parameter 
Study participants (n = 6); 
median (range) 
Reference values for men < 60 
years [35] (range) 
LA area 4C [cm2] 24 (18–30) 15–29 
RA area 4C [cm2] 22 (20–30) 14–30 
LV EDV [mL] 182 (152–245) 119–203 
LV ESV [mL] 76 (60–107) 33–77 
LV EF [%] 59 (53–62) 57–75 
LV mass [g] 165 (155–199) 107–187 
RV EDV [mL] 202 (184–239) 119–219 
RV ESV [mL] 115 (97–123) 32–92 
RV EF [%] 46 (42–49) 50–78 
For abbreviations see Table 2; LA — left atrial; RA — right atrial; 4C — four chamber view; 
RV EF — right ventricular ejection fraction; ESV — end-systolic volume 
 
 
 
